Furthermore, hMSCs showed low efficiency in improving the colitis in B cell-depleted mice while adaptive transfer of CD23+CD43+ B cells significantly ameliorated the clinical and histopathological severity of induced colonic inflammation and restored the injured gastrointestinal mucosal tissues. This evidence concerns the gene SPN and colitis.